Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2026)
Recursion Pharmaceuticals' (RXRX) quarterly Tax Rate came in at 3.77% in Q1 2026, up 369.0% YoY from 0.8% in Q1 2025, and up 20479.57% on a QoQ basis from 0.02% in Q4 2025.
Recursion Pharmaceuticals (RXRX) Tax Rate (2023 - 2026) Analysis & Trends
Recursion Pharmaceuticals (RXRX) has 4 years of Tax Rate data on file, last reported at 3.77% in Q1 2026.
- Quarterly Tax Rate rose 369.0% year-over-year to 3.77% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.81% (up 72.0% YoY) and the FY2025 annual result came in at 0.02%, down 22.0% from the prior year.
- Tax Rate grew to 3.77% in Q1 2026, from 0.02% in the prior quarter.
- In the past five years, Tax Rate ranged from a high of 4.19% in Q4 2023 to a low of 0.17% in Q3 2024.
- A 4-year average of 1.02% and a median of 0.08% in 2025 frame the typical range for Tax Rate.
- Annual changes were most pronounced in 2024 — Tax Rate slumped 419 bps — and 2026, when it surged 369 bps.
- Tracing RXRX's Tax Rate over 4 years: stood at 4.19% in 2023, then sank by 100 bps to 0.0% in 2024, then sank by 373 bps to 0.02% in 2025, then soared by 20480 bps to 3.77% in 2026.
- The last three Tax Rate figures came in at 3.77% (Q1 2026), 0.02% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 10.91% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 24.15% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -9.47% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 7.49% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -16.71% |
| 10 | Recursion Pharmaceuticals | 1.69 Bn | 1.14 Bn | -3.82 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Jun 30, 2026 | 0.00% |
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 3.77% |
| Mar 31, 2026 | 3.77% |
| Mar 31, 2026 | 3.77% |
| Dec 31, 2025 | -0.02% |
| Dec 31, 2025 | -0.02% |
| Dec 31, 2025 | -0.02% |
| Sep 30, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.08% |
| Mar 31, 2025 | 0.08% |
| Mar 31, 2025 | 0.08% |
| Dec 31, 2024 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | -0.17% |
| Sep 30, 2024 | -0.17% |